Postoperative Ileus Market
Feb 27, 2026
Postoperative Ileus Treatment: Innovation Lag in a High-Burden Market
Summary In 2024, the 7MM reported an estimated 772K new cases of postoperative ileus. FDA-approved treatment options include metoclopramide (REGLAN), neostigmine (PROSTIGMIN), and alvimopan (ENTEREG), all of which face generic competition, with alvimopan losing market exclusivity in 2024. The development ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
